Peter Lindy, MD
Orthopaedic Surgery · Memphis, TNNPI 1558323501
Payments from drug & device makers
Across 42 payments — averaging $76.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gentleman Orthopedic Solutions$1K
- Arthrex$589
- Conformis, Inc.$290
- BD$240
- Restor3d, Inc.$160
- Smith+Nephew$140
- plus $596 from 17 others
What the payments were for
- Consulting fees$2407%
- Travel & lodging$46815%
- Food & beverage$1,30741%
- Education$1,20037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gentleman Orthopedic Solutions | 1 | $1,200 |
| Arthrex | 9 | $589 |
| Conformis, Inc. | 4 | $290 |
| BD | 1 | $240 |
| Restor3d, Inc. | 1 | $160 |
| Smith+Nephew | 1 | $140 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Ferring Pharmaceuticals Inc. | 4 | $74 |
| Bioventus LLC | 2 | $54 |
| Heron Therapeutics, Inc. | 2 | $47 |
| Innovation Technologies Inc | 1 | $42 |
| Convatec Inc. | 2 | $39 |
| Medtronic | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Solventum Corporation | 1 | $27 |
| Johnson & Johnson | 1 | $24 |
| Osiris Therapeutics Inc. | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| KCI USA, Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,216 in reported general payments places this provider in the 40th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $9,659 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 217 | $2,574 |
| Diclofenac Sodium | 91 | $1,131 |
| Meloxicam | 260 | $1,047 |
| Cyclobenzaprine Hcl | 53 | $582 |
| Methylprednisolone | 72 | $500 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $446 |
| Nabumetone | 17 | $359 |
| Celecoxib | 30 | $326 |
| Ibuprofen | 14 | $212 |
| Tramadol Hcl | 39 | $167 |
| Gabapentin | 15 | $106 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Memphis
- Michael BeebeMemphis$679K
- William FergusonMemphis$49K
- Paul BradyKnoxville$20.1M
- Jesse DotyChattanooga$2.5M
- Edwin SpencerKnoxville$2.5M
- Thomas ThrockmortonGermantown$1.9M
- Tyler BrolinCollierville$1M
- Jefferson MorrisonNashville$910K
- Matthew WillisNashville$850K
- Alton HunterColumbia$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.